AARTIDRUGS Intraday Analysis...

AARTIDRUGS Share Price

Open 528.00 Change Price %
High 540.95 1 Day 6.25 1.18
Low 513.00 1 Week 20.50 3.97
Close 536.55 1 Month 35.05 6.99
Volume 27534 1 Year 89.60 20.05
52 Week High 686.45
52 Week Low 445.65
AARTIDRUGS Important Levels
Resistance 2 562.46
Resistance 1 551.78
Pivot 530.17
Support 1 521.32
Support 2 510.64
NSE INDIA Most Active Stocks
JPASSOCIAT 21.00 12.00%
GMRINFRA 19.25 -9.84%
RCOM 21.70 2.36%
JPPOWER 5.40 17.39%
UNITECH 5.40 6.93%
SBIN 279.65 -3.22%
IBREALEST 206.15 0.83%
SUZLON 18.10 -1.63%
ICICIBANK 287.90 -1.35%
SOUTHBANK 27.55 -1.78%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.15 50.00%
VISESHINFO 0.15 50.00%
ATNINTER 0.20 33.33%
EXCEL 53.75 19.98%
MANAKSTEEL 20.25 19.82%
JPINFRATEC 14.90 19.68%
KARMAENG 55.20 17.57%
JPPOWER 5.40 17.39%
SPCENET 0.45 12.50%
JPASSOCIAT 21.00 12.00%
More..
NSE INDIA Top Losers Stocks
AUSTRAL 0.15 -25.00%
NAKODA 0.35 -12.50%
ALMONDZ 18.05 -10.20%
GMRINFRA 19.25 -9.84%
SITASHREE 3.95 -9.20%
CASTEXTECH 7.20 -8.86%
TAINWALCHM 63.20 -8.60%
JYOTISTRUC 10.10 -8.60%
INDOTECH 180.05 -8.58%
GUJNRECOKE 1.70 -8.11%
More..

Aarti Drugs Limited (NSE: AARTIDRUGS)

AARTIDRUGS Technical Analysis 1.5
As on 27th Jun 2017 AARTIDRUGS Share Price closed @ 536.55 and we RECOMMEND Sell for LONG-TERM with Stoploss of 574.64 & Buy for SHORT-TERM with Stoploss of 532.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
AARTIDRUGS Target for June
1st Target up-side 552.97
2nd Target up-side 601.35
3rd Target up-side 649.73
1st Target down-side 414.93
2nd Target down-side 366.55
3rd Target down-side 318.17
AARTIDRUGS Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 61.81 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 501.98
10 Day Avg Volume Traded 71.96 % More then 10 Day Average Volume
AARTIDRUGS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.aartidrugs.com
AARTIDRUGS Address
AARTIDRUGS
Mahendra Industrial Estate
Ground Floor
Mumbai, 400022
India
Phone: 91 22 2401 9025
Fax: 91 22 2407 3462
AARTIDRUGS Latest News
Aarti Drugs Ltd Fixes Record Date for 1:1 Bonus Issue   Equity Bulls   - 19th Mar 15
Aarti Drugs - Board Meeting on March 26, 2015   Moneycontrol.com   - 17th Mar 15
Newspapers Advertisement of Result of Postal Ballot   Hindu Business Line   - 16th Mar 15
Here are six things that you need to know about Aarti Drugs   Moneycontrol.com   - 16th Feb 15
Aarti Drugs hits new high on 1:1 bonus issue; strong Q3 results   Business Standard   - 02nd Feb 15
Aarti Drugs Board approves bonus issue   Indiainfoline   - 30th Jan 15
Aarti Drugs to consider second interim dividend   Moneycontrol.com   - 19th Jan 15
Buy Aarti Drugs; target of Rs 1031: Sunidhi Securities   Moneycontrol.com   - 12th Aug 14
Aarti Drugs eyes to buy a Baddi company for toll manufacturing   Business Standard   - 07th Jul 14
USFDA issues warning letter to Mumbai-based Aarti Drugs   Business Standard   - 25th Sep 13
Interactive Technical Analysis Chart Aarti Drugs Limited ( AARTIDRUGS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aarti Drugs Limited
AARTIDRUGS Business Profile
Aarti Drugs Limited was incorporated on 28th September, 1984 as a Private Limited Company and then it was converted into a Public Limited Company on 1st July, 1992.The Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved. Aarti Drugs has reported a standalone sales turnover of Rs 218.64 crore and a net profit of Rs 11.84 crore for the quarter ended June 2013. The registered office is at Plot No. N - 198, M.I.D.C., Tarapur, Village - Pamtembhi, Taluka - Palghar, District Thane - 401 506 in Maharashtra and Corporate office is at Mahendra Industrial Estate, Ground Floor, Road No 29, Plot No 109-D, SION, Mumbai.